Forbes Names PPD One of North Carolina’s Best Employers
With worldwide headquarters in
PPD’s strong corporate culture is essential to driving high performance, and the company’s defining principle of being game changers inspires employees to implement innovative strategies to address the challenges of drug development. Today, this includes critical work to accelerate customers’ potential vaccines and therapeutics for COVID-19.
“PPD is a great place to work because of our employees’ dedication to our shared mission of improving health,” said
Forbes selected America’s Best-In-State Employers based on an independent survey of more than 80,000
The evaluation was made on a state-by-state approach and is based on two distinct criteria: employees’ willingness to recommend their own employers to friends and family; and employees’ opinions on a series of statements surrounding work-related topics such as working conditions, salary, potential for development and company image regarding their current employer.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 24,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppd.com.
This news release contains forward-looking statements. These statements often include words such as “expect,” “believe,” “project,” “forecast,” “estimate,” “target” and other similar expressions. Although we believe these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our actual financial results, and therefore actual results might differ materially from those expressed in the forward-looking statements. Factors that might materially affect such forward-looking statements include, but are not limited to, the fragmented and highly competitive nature of the drug development services industry; changes in trends in the biopharmaceutical industry; our ability to keep pace with rapid technological changes that could make our services less competitive or obsolete; political, economic and/or regulatory influences and changes; and other factors disclosed under the “Risk Factors” section in our periodic reports filed with the
+1 919 456 6389
+1 910 558 2899